Summary

  • TTM agreed to pay $1.1 billion cash for Epiq Solutions, then priced $500 million of 6.750% unsecured notes alongside commitments for a $300 million secured term-loan A and an $800 million secured term-loan B.
  • The three headline amounts are not a cumulative acquisition bill: the commitment letter permits qualifying alternative financing proceeds to reduce incremental facilities dollar for dollar, while stated uses include fees, Epiq debt and possible repayment of revolver borrowing for another acquisition.
  • TTM expects net leverage of 2.3 times at closing and 1.5–1.7 times within 12–18 months, but the disclosed record does not yet provide the final debt draws, net proceeds, acquired cash and debt or adjusted-EBITDA bridge needed to reproduce that path.

The easiest mistake in TTM Technologies’ proposed acquisition of Epiq Solutions is addition.

TTM has agreed to pay $1.1 billion in cash. It first secured commitments for a $300 million term-loan A and an $800 million term-loan B. On 10 September it priced $500 million of 6.750% senior notes due 2034. The visible figures sum to $1.6 billion, half a billion more than the purchase price.

That arithmetic is correct and the conclusion it invites is wrong. These are financing capacities and securities, not three receipts stapled to one purchase cheque. The August commitment letter allows the incremental facilities to be reduced dollar for dollar by net cash proceeds actually received from other financing that TTM elects to use for the acquisition. The September release describes the notes and expected facility borrowings together, but also gives the proceeds a broader perimeter: the Epiq price, general corporate purposes, related costs and possible reduction of revolver borrowings used for TTM’s separate acquisition of Swiss Technology Group. The initial facilities also contemplated refinancing certain Epiq debt.

The funding stack is therefore a set of communicating vessels. Issuing more in one instrument can reduce or displace another; drawing a facility can bridge timing rather than establish permanent capital; gross proceeds can be consumed by discounts and fees; and cash left after an acquisition use can move elsewhere within the stated mandate. Until closing produces a final sources-and-uses schedule, “$1.6 billion of financing” describes the perimeter of choices, not the liability created by buying Epiq.

Six verbs separate a commitment from a debt burden

A disciplined reading needs six stages: committed, priced, closed, drawn, used and repaid. The market often compresses them into “financed,” erasing the decisions that matter.

The banks committed in August to arrange the two incremental senior secured facilities under TTM’s existing credit agreement. JPMorgan, Barclays and Bank of America took specified shares; their obligations are several, not joint, and subject to limited conditions. The $800 million term-loan B has a seven-year tenor. The term-loan A is $300 million. Those commitments gave the buyer credible access to funds, but the 8-K explicitly says neither closing the facilities nor receiving any other financing is a condition to TTM’s acquisition obligation.

The notes have moved one step further: they have been priced, with sale expected to close on 24 September subject to customary conditions. They will be senior unsecured obligations, guaranteed by subsidiaries that guarantee TTM’s secured facilities, subject to exceptions. That guarantee overlap does not erase the difference in collateral. The term lenders are secured; the noteholders are not. A common guarantor can support both groups while recovery order and covenant influence remain different.

The deal and the notes are deliberately asynchronous. The offering is not conditioned on the acquisition, and the acquisition is not conditioned on the offering. If Epiq has not closed by 15 November 2026—subject to an automatic extension to 15 May 2027 in certain circumstances—or TTM determines it will not close by that outside date, the notes carry a special mandatory redemption at 100% plus accrued and unpaid interest. That provision limits how long deal-specific unsecured capital can remain outstanding after the deal fails.

It does not make the intervening period costless, nor does it solve TTM’s obligation to close if purchase conditions are satisfied and financing is not.

This separation is the first control surface. Treasury can choose the permanent mix, but it cannot pretend every stage is simultaneous. Investors should record the close of the notes, the amended facility amounts, actual borrowings and acquisition completion as separate events.

The $500 million difference already has several claimants

The apparent surplus over the $1.1 billion purchase price is not necessarily excess cash. It may not exist as a cumulative sum at all because of the substitution clause. Even if gross debt raised exceeds the cheque, there are other calls on it.

The purchase price is subject to working-capital and other customary adjustments. The facilities were described as covering fees, costs and expenses as well as refinancing certain Epiq indebtedness. The notes release adds general corporate purposes and specifically contemplates reducing any revolver amount that TTM may borrow to fund Swiss Technology Group. Original issue discount and underwriting or arrangement fees turn gross principal into smaller net proceeds. Acquired cash, if any, moves the opposite way.

These items belong in one bridge, but not in one label. Paying Epiq’s seller is purchase consideration. Refinancing target debt changes the acquired capital structure. Repaying an STG bridge allocates capital to a different transaction. Fees are transaction leakage. Retaining cash increases liquidity. Each can be legitimate; each has a different implication for enterprise value, net debt and the time required to deleverage.

TTM entered the transaction from a substantial liquidity position. At 29 June it reported about $507.9 million of cash, including $185.4 million at foreign subsidiaries, and $913.9 million of available revolving capacity. It also had $973.5 million of outstanding debt net of discounts and issuance costs: $497.8 million of notes due 2029, $395.7 million under its amended term loan and $80 million under the revolver.

Those figures do not reveal the closing mix. Foreign cash may entail tax or operating constraints; existing revolver capacity is availability, not free money; and the balance sheet has other demands. TTM generated $118.2 million of operating cash in the first half, while property, plant and equipment and other asset purchases used $169.2 million. Management expected $345–365 million of 2026 capital expenditure. Epiq financing competes with a capacity programme rather than sitting on an empty balance sheet.

Priority is part of price even when the coupon is visible

The 6.750% coupon makes the unsecured notes easy to model. The secured loans require a different map. The commitment letter linked their floating rates to term SOFR or an alternative base rate plus margins, with term-loan A pricing moving through a leverage grid and term-loan B initially carrying a separate margin. Final syndication, discounts and any flex affect the realised cost.

More important, secured borrowing pledges a recovery surface. It can be cheaper because lenders receive collateral and covenant protections that unsecured creditors lack. Unsecured notes may preserve collateral flexibility, but an eight-year fixed coupon remains payable even if anticipated synergies arrive late. Comparing only headline interest rates would miss the value and restrictions assigned to each creditor group.

The subsidiary guarantees create another boundary. The note guarantee comes from subsidiaries that guarantee senior secured facilities, with exceptions. Readers need the final guarantor set, excluded subsidiaries, collateral package and pro-forma priority diagram. “Guaranteed” cannot be used as a synonym for “secured,” and “senior” does not mean every senior claim recovers equally.

This matters because TTM is not financing a passive financial asset. Epiq operates higher in the electronics stack, selling systems and modules into mission markets. Working capital, programme timing, customer acceptance and product investment can move cash conversion independently of adjusted EBITDA. A capital structure that looks conservative on a projected multiple can become restrictive when cash arrives later than earnings.

The 17.4-times multiple contains an unpublished denominator

TTM’s transaction release values Epiq at 17.4 times expected 2027 adjusted EBITDA after $9 million of run-rate synergies. Dividing $1.1 billion by 17.4 yields roughly $63.2 million. That is useful as a check on the implied denominator, not a reported historical EBITDA figure.

The investor presentation says TTM cannot predict the reconciling items needed to connect expected Epiq adjusted EBITDA to a comparable GAAP measure without unreasonable effort. The measure is forward-looking, includes a synergy assumption and may not be comparable with another company’s adjusted EBITDA. The source set does not publish Epiq’s historic revenue, GAAP earnings, working-capital pattern, customer concentration or a reconciliation from current performance to the 2027 denominator.

That does not make the multiple unusable. It makes it conditional. A proper receipt would separate stand-alone EBITDA, organic growth, the timing and cost of the $9 million synergy, stock compensation or other exclusions, and the cash required to produce the earnings. If the denominator expands through adjustments faster than cash, the purchase multiple can fall on paper without reducing debt.

TTM also expects immediate adjusted-EBITDA-margin accretion and non-GAAP EPS accretion during 2028. Margin accretion can coexist with higher interest expense. EPS accretion can coexist with slower debt reduction. Neither claim answers how much secured and unsecured capital will remain after closing.

RF breadth explains the strategy, not the financing return

The industrial logic is more specific than generic scale. TTM describes Epiq as a provider of open-architecture software-defined radios, RF products and radiation-tolerant space compute used in signals intelligence, electronic warfare, surveillance and communications. The presentation places Epiq’s systems above TTM’s existing component and subsystem capabilities and argues that the combination spans a broad RF range.

That may give TTM more content per programme, deeper customer contact and access to longer-cycle mission work. It also moves the company upward from manufacturing components toward integrated products where software, security accreditation, programme concentration and product road maps matter. The source set supports the strategic intention. It does not independently establish award conversion, pricing power or realised cash returns.

The acquisition therefore deserves two ledgers. The operating ledger should track programme backlog, bookings, deliveries, customer concentration, gross margin and R&D. The capital ledger should track funded debt, interest, cash taxes, integration spending, synergies and repayment. Strategic fit belongs in the first; the deleveraging claim is proved only in the second.